HSBC Holdings
RCUS icon

HSBC Holdings’s Arcus Biosciences RCUS Stock Holding History

HSBC Holdings’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,821
Closed -$283K – 2983
2022
Q4 		$283K Buy
+13,821
New +$380K ﹤0.01% 2586
2021
Q1 		– Sell
-14,846
Closed -$385K – 3054
2020
Q4 		$385K Buy
14,846
+3,823
+35% +$92.5K ﹤0.01% 2382
2020
Q3 		$191K Buy
+11,023
New +$246K ﹤0.01% 2488

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HSBC Holdings's RCUS Position: Q1 2023 in Review

HSBC Holdings sold out of Arcus Biosciences (RCUS) in Q1 2023, closing a stake of 13,821 shares — an estimated $283K sold.

HSBC Holdings first reported a position in RCUS in Q3 2020 and held it in 3 quarters. The position peaked at $385K in Q4 2020. 179 funds tracked by Wall St. Rank hold RCUS as of Q1 2023.

  • HSBC Holdings reported no remaining Arcus Biosciences position as of Q1 2023 after selling out during the quarter.
  • HSBC Holdings sold 13,821 Arcus Biosciences shares in Q1 2023, an estimated $283K.
  • HSBC Holdings first reported a position in Arcus Biosciences in Q3 2020 and held it in 3 quarters.
  • HSBC Holdings's Arcus Biosciences position peaked at $385K in Q4 2020.
  • 179 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.